Please assess the completion status of the following clinical trial:

Trial Title: Pharmacodynamic and Pharmacokinetic Study of 2 Different Dose Regimen of Clopidogrel in CYP2C19 Genotyped Healthy Subjects

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~Healthy subject in good health, as determined by a medical history, physical examination including vital signs and clinical laboratory tests:~* with a body weight between 45 kg and 95 kg if male, between 40 kg and 85 kg if female, and with a Body Mass Index (BMI) between 18 and 30 kg/m²~* classified into one of the 4 groups of metabolizers according to his/her CYP2C19 genotype:~  * Ultrarapid Metabolizers (UMs, CYP2C19\*1/\*17 and CYP2C19\*17/\*17)~ * homozygous Extensive Metabolizers (homoEMs, CYP2C19\*1/\*1)~ * heterozygous Extensive Metabolizers (heteroEMs, CYP2C19\*1/\*2 and CYP2C19\*1/\*3)~ * Poor Metabolizers (PMs, CYP2C19\*2/\*2 and CYP2C19\*2/\*3)~Exclusion criteria:~* Evidence of inherited disorder of coagulation/hemostasis functions~* Subject smoking more than 10 cigarettes or equivalent per day~* Unability to abstain from intake of any drug affecting hemostasis throughout the whole study duration~The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Sequence clopidogrel 300/75 mg - 600/150 mg (Type: EXPERIMENTAL): Period 1:~* Day 1: clopidogrel, 300 mg loading dose + placebo~* Day 2 to Day 5: clopidogrel, 75 mg + placebo, once daily~Period 2:~* Day 1: clopidogrel, 600 mg loading dose~* Day 2 to Day 5: clopidogrel, 150 mg, once daily~Each intake is at around 8:00 AM fasted for at least 10 hours
- Sequence clopidogrel 600/150 mg - 300/75 mg (Type: EXPERIMENTAL): Period 1:~* Day 1: clopidogrel, 600 mg loading dose~* Day 2 to Day 5: clopidogrel, 150 mg, once daily~Period 2:~* Day 1: clopidogrel, 300 mg loading dose + placebo~* Day 2 to Day 5: clopidogrel, 75 mg + placebo, once daily~Each intake is at around 8:00 AM fasted for at least 10 hours

Based on this trial design, predict the completion outcome and termination type (if applicable).